Most Read Articles
3 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).

T2D effect on dementia varies by subtype

Roshini Claire Anthony
02 Oct 2020

Type 2 diabetes (T2D) may be associated with an elevated risk of dementia, but the effect varies according to dementia subtype, according to a study presented at EASD 2020.

“Individuals with T2D have a higher risk of all-cause dementia. However, the risk was higher for vascular dementia compared to other forms of dementia, such as Alzheimer’s disease (AD) and non-vascular dementia,” presented study author Dr Carlos Celis-Morales from the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.

A total of 378,299 adults with T2D (mean age 64.13 years, 54.7 percent male) listed in the Swedish National Diabetes Register in 1998–2013 were age- and sex-matched with 1,886,022 controls from the general population (mean age 64.07 years, 54.8 percent male). They were followed up for a median 6.7 years, during which time, 10,143 patients with T2D and 46,479 controls developed dementia.

Initial analysis suggested the association between T2D and dementia was highest for vascular dementia (hazard ratio [HR], 1.35) compared with the control group, with a less evident association between T2D and non-vascular dementia (HR, 1.08). Conversely, the risk of AD appeared lower in the T2D vs control group (HR, 0.92). [EASD 2020, oral abstract 6]

The effect of T2D on the various dementia subtypes appeared to be influenced by glycaemic control (ie, HbA1c levels). Individuals with T2D with poor glycaemic control (HbA1c 87 mmol/mol) had an almost twofold risk of vascular dementia (HR, 1.93, 95 percent confidence interval [CI], 1.53–2.42) compared with those with better glycaemic control (HbA1c <52 mmol/mol).

The risks of non-vascular dementia (HR, 1.67, 95 percent CI, 1.45–1.91) and AD (HR, 1.34, 95 percent CI, 1.03–1.75) were also increased among patients with HbA1c 87 vs <52 mmol/mol.

In a landmark analysis at 3 years, the risks remained elevated for vascular and non-vascular dementia, but not AD.

The results also showed that modifiable and non-modifiable risk factors had different impacts on the various dementia subtypes.

For instance, cardiovascular disease (CVD)-related factors explained up to 40 percent of the relative influence of T2D on vascular dementia, and only 10 and 20 percent of the relative influence of T2D on AD and non-vascular dementia, respectively, said Celis-Morales.

BMI and blood pressure, which were among the key modifiable risk factors explaining the T2D–dementia risk, have significant “public health relevance”, he continued. “[I]dentification of high-risk individuals and tailored interventions of treatment could attenuate the dementia risk attributable to T2D,” he said.

“[O]ur findings underscore the importance of good blood sugar control,” he continued. “[However, they] by no means suggest that most who have diabetes will go on to develop vascular dementia in later life. But with the number of people with T2D doubling over the past 30 years, the importance of a healthy lifestyle is clearer than ever,” he said.

Echoing this was study co-author Professor Naveed Sattar, also from the University of Glasgow. “A 36 percent higher risk is in itself an argument for preventive measures such as healthier lifestyle.”

“Diabetes and dementia share certain risk factors that might contribute to these associations including obesity, smoking, and lack of physical activity. The importance of prevention is underscored by the fact that, for the majority of dementia diseases, there is no good treatment,” he pointed out.

The authors acknowledged the potential for residual confounding and that the observational study design precluded conclusions on cause and effect. Studies with longer follow-up may help establish the findings, considering that dementia onset often occurs several years prior to diagnosis, they said. 

 

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
3 days ago
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Tristan Manalac, 18 Nov 2020
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).